These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22964442)

  • 1. Does a normalizing electroencephalogram in benign childhood epilepsy with centrotemporal spikes abort attention deficit hyperactivity disorder?
    Schneebaum-Sender N; Goldberg-Stern H; Fattal-Valevski A; Kramer U
    Pediatr Neurol; 2012 Oct; 47(4):279-83. PubMed ID: 22964442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
    van der Feltz-Cornelis CM; Aldenkamp AP
    Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention deficit/hyperactivity disorder and interictal epileptiform discharges: it is safe to use methylphenidate?
    Socanski D; Aurlien D; Herigstad A; Thomsen PH; Larsen TK
    Seizure; 2015 Feb; 25():80-3. PubMed ID: 25645642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and electroencephalographic features of benign childhood epilepsy with centrotemporal spikes comorbidity with attention-deficit hyperactivity disorder in Southwest China.
    Huang C; Hu W; Tan G; Xu Y; Liu L
    Epilepsy Behav; 2020 Oct; 111():107240. PubMed ID: 32603807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cognitive response to extended-release methylphenidate (Medikinet) in attention deficit/hyperactivity disorder: efficacy evaluation.
    Fernández-Jaén A; Fernández-Mayoralas DM; Pardos A; Calleja-Pérez B; Muñoz Jareño N
    Adv Ther; 2009 Dec; 26(12):1097-110. PubMed ID: 20082241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes.
    Kramer U; Shahar E; Zelnik N; Lerman-Sagie T; Watemberg N; Nevo Y; Ben-Zeev B
    J Child Neurol; 2002 Dec; 17(12):914-6. PubMed ID: 12593467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical benign epilepsy of childhood with rolandic spikes: features of a subset requiring more than one medication for seizure control.
    Al-Twajri WA; Shevell MI
    J Child Neurol; 2002 Dec; 17(12):901-4. PubMed ID: 12593463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological management of attention deficit hyperactivity disorder with methylphenidate and atomoxetine within a context of epilepsy].
    Mulas F; Roca P; Ros-Cervera G; Gandía-Benetó R; Ortiz-Sánchez P
    Rev Neurol; 2014 Feb; 58 Suppl 1():S43-9. PubMed ID: 25252667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attention-deficit disorders and epilepsy in childhood: incidence, causative relations and treatment possibilities.
    Kaufmann R; Goldberg-Stern H; Shuper A
    J Child Neurol; 2009 Jun; 24(6):727-33. PubMed ID: 19491115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of a youth with ADHD and a seizure disorder.
    Gonzalez-Heydrich J; Weiss M; Connolly M; Wambera K; Jan JE; Plioplys S; Dunn DW; Kratochvil CJ
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1527-32. PubMed ID: 17135999
    [No Abstract]   [Full Text] [Related]  

  • 12. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment.
    Torres AR; Whitney J; Gonzalez-Heydrich J
    Epilepsy Behav; 2008 Feb; 12(2):217-33. PubMed ID: 18065271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methylphenidate on the quality of life in children with epilepsy and attention deficit hyperactivity disorder: and open-label study using an osmotic-controlled release oral delivery system.
    Yoo HK; Park S; Wang HR; Lee JS; Kim K; Paik KW; Yum MS; Ko TS
    Epileptic Disord; 2009 Dec; 11(4):301-8. PubMed ID: 20007067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate-induced acute orofacial and extremity dyskinesia.
    Yilmaz AE; Donmez A; Orun E; Tas T; Isik B; Sonmez FM
    J Child Neurol; 2013 Jun; 28(6):781-3. PubMed ID: 22791547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and EEG characteristics of benign rolandic epilepsy in Chinese patients.
    Zhao X; Chi Z; Chi L; Shang W; Liu X
    Brain Dev; 2007 Jan; 29(1):13-8. PubMed ID: 16806777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic evaluation and therapeutic basis of immediate release methylphenidate in attention deficit hyperactivity disorder].
    Valdizán JR
    Rev Neurol; 2004 Mar 16-31; 38(6):501-6. PubMed ID: 15054710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate.
    Gadow KD; Sverd J
    Adv Neurol; 2006; 99():197-207. PubMed ID: 16536367
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attention deficit hyperactivity disorder and epilepsy in childhood].
    Idiazábal-Alecha MA; Kosno M
    Rev Neurol; 2012 Feb; 54 Suppl 1():S89-93. PubMed ID: 22374777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atonic variant of benign childhood epilepsy with centrotemporal spikes (atonic-BECTS): a distinct electro-clinical syndrome.
    Cherian A; Baheti NN; Menon RN; Iyer RS; Rathore C; Radhakrishnan A
    Brain Dev; 2012 Jun; 34(6):511-9. PubMed ID: 21982812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the electroencephalogram in attention deficit hyperactivity disorder.
    Millichap JG; Millichap JJ; Stack CV
    Clin EEG Neurosci; 2011 Jul; 42(3):180-4. PubMed ID: 21870470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.